166 related articles for article (PubMed ID: 19010369)
21. Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine.
Rose MA; Schubert R; Strnad N; Zielen S
Clin Diagn Lab Immunol; 2005 Oct; 12(10):1216-22. PubMed ID: 16210486
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of pneumococcal vaccination of patients with cochlear implants.
Rose M; Hey C; Kujumdshiev S; Gall V; Schubert R; Zielen S
J Infect Dis; 2004 Aug; 190(3):551-7. PubMed ID: 15243931
[TBL] [Abstract][Full Text] [Related]
23. Antibody persistence 5 years after a 13-valent pneumococcal conjugate vaccine in asplenic patients with β-thalassemia: assessing the need for booster.
Papadatou I; Lagousi T; Kattamis A; Spoulou V
Ann Hematol; 2019 Mar; 98(3):775-779. PubMed ID: 30683996
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.
Goldblatt D; Southern J; Ashton L; Richmond P; Burbidge P; Tasevska J; Crowley-Luke A; Andrews N; Morris R; Borrow R; Cartwright K; Miller E
Pediatr Infect Dis J; 2006 Apr; 25(4):312-9. PubMed ID: 16567982
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide-protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Jackson LA; Neuzil KM; Nahm MH; Whitney CG; Yu O; Nelson JC; Starkovich PT; Dunstan M; Carste B; Shay DK; Baggs J; Carlone GM
Vaccine; 2007 May; 25(20):4029-37. PubMed ID: 17391816
[TBL] [Abstract][Full Text] [Related]
26. Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.
Reinert P; Benkerrou M; de Montalembert M; Lesprit E; Abadie I; Bernaudin F; Doit C; Bingen E; Tetelboum R; Bonnet E
Pediatr Infect Dis J; 2007 Dec; 26(12):1105-9. PubMed ID: 18043446
[TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of sequential pneumococcal immunization in preschool asthmatics.
Rose MA; Gruendler M; Schubert R; Kitz R; Schulze J; Zielen S
Vaccine; 2009 Aug; 27(38):5259-64. PubMed ID: 19576944
[TBL] [Abstract][Full Text] [Related]
28. A murine model for the study of immune memory in response to pneumococcal conjugate vaccination.
Moreno RL; Sampson JS; Romero-Steiner S; Wong B; Johnson SE; Ades E; Carlone GM
Vaccine; 2004 Aug; 22(23-24):3069-79. PubMed ID: 15297057
[TBL] [Abstract][Full Text] [Related]
29. Essential criteria for evaluation of pneumococcal conjugate vaccine candidates.
Paradiso P
Vaccine; 2009 Aug; 27 Suppl 3():C15-8. PubMed ID: 19683657
[TBL] [Abstract][Full Text] [Related]
30. Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.
Jackson LA; Neuzil KM; Whitney CG; Starkovich P; Dunstan M; Yu O; Nelson JC; Feikin DR; Shay DK; Baggs J; Carste B; Nahm MH; Carlone G
Vaccine; 2005 May; 23(28):3697-703. PubMed ID: 15882530
[TBL] [Abstract][Full Text] [Related]
31. Immunological efficacy of a prime-boost pneumococcal vaccination in HIV-infected adults.
Lesprit P; Pédrono G; Molina JM; Goujard C; Girard PM; Sarrazin N; Katlama C; Yéni P; Morineau P; Delfraissy JF; Chêne G; Lévy Y;
AIDS; 2007 Nov; 21(18):2425-34. PubMed ID: 18025879
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma.
Rose MA; Schubert R; Kujumdshiev S; Kitz R; Zielen S
Int J Clin Pract; 2006 Nov; 60(11):1425-31. PubMed ID: 17073839
[TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy.
Russell FM; Licciardi PV; Balloch A; Biaukula V; Tikoduadua L; Carapetis JR; Nelson J; Jenney AW; Waqatakirewa L; Colquhoun S; Cheung YB; Tang ML; Mulholland EK
Vaccine; 2010 Apr; 28(18):3086-94. PubMed ID: 20199764
[TBL] [Abstract][Full Text] [Related]
34. Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with β-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine.
Papadatou I; Piperi C; Alexandraki K; Kattamis A; Theodoridou M; Spoulou V
Clin Infect Dis; 2014 Sep; 59(6):862-5. PubMed ID: 24879786
[TBL] [Abstract][Full Text] [Related]
35. Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: no evidence of hyporesponsiveness.
Hammitt LL; Bulkow LR; Singleton RJ; Nuorti JP; Hummel KB; Miernyk KM; Zanis C; Whaley M; Romero-Steiner S; Butler JC; Rudolph K; Hennessy TW
Vaccine; 2011 Mar; 29(12):2287-95. PubMed ID: 21255685
[TBL] [Abstract][Full Text] [Related]
36. Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine.
Miiro G; Kayhty H; Watera C; Tolmie H; Whitworth JA; Gilks CF; French N
J Infect Dis; 2005 Nov; 192(10):1801-5. PubMed ID: 16235180
[TBL] [Abstract][Full Text] [Related]
37. Natural and vaccine-induced immunity against Haemophilus influenzae type b in patients with beta-thalassemia.
Spoulou VI; Tsoumas DL; Ladis V; Spentzou A; Theodoridou MC
Vaccine; 2006 Apr; 24(16):3050-3. PubMed ID: 16519975
[TBL] [Abstract][Full Text] [Related]
38. Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy, Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children.
Kamchaisatian W; Wanwatsuntikul W; Sleasman JW; Tangsinmankong N
J Allergy Clin Immunol; 2006 Dec; 118(6):1336-41. PubMed ID: 17157665
[TBL] [Abstract][Full Text] [Related]
39. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity.
Bermal N; Szenborn L; Chrobot A; Alberto E; Lommel P; Gatchalian S; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S89-96. PubMed ID: 19325451
[TBL] [Abstract][Full Text] [Related]
40. A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults.
Lazarus R; Clutterbuck E; Yu LM; Bowman J; Bateman EA; Diggle L; Angus B; Peto TE; Beverley PC; Mant D; Pollard AJ
Clin Infect Dis; 2011 Mar; 52(6):736-42. PubMed ID: 21367726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
